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ABSTRACT: Formation of crystalline biofilms following infection by Proteus mirabilis can lead to encrustation and blockage 
of long-term indwelling catheters, with serious clinical consequences. We describe a simple sensor, placed within the cath-
eter drainage bag, to alert of impending blockage via a urinary color change. The pH-responsive sensor is a dual-layered 
polymeric ‘lozenge’, able to release the self-quenching dye 5(6)-carboxyfluorescein in response to the alkaline urine gener-
ated by the expression of bacterial urease. Sensor performance was evaluated within a laboratory model of the catheterized 
urinary tract, infected with both urease positive and negative bacterial strains under conditions of established infection, 
achieving an average ‘early warning’ of catheter blockage of 14.5 hours. Signaling only occurred following infection with 
urease positive bacteria. Translation of these sensors into a clinical environment would allow appropriate intervention be-
fore the occurrence of catheter blockage, a problem for which there is currently no effective control method. 
Catheter-associated urinary tract infection (CAUTI) ac-
counts for approximately 80% of nosocomial infections 
worldwide 1. Foley catheters are often used on a long-term 
(≥30 days) indwelling basis as a common management 
technique for urinary incontinence or retention, and are 
universally complicated by polymicrobial and dynamic 
bacteriuria 2. Specifically, infections caused by the Gram-
negative, motile bacterium Proteus mirabilis (P. mirabilis) 
comprise 20-45% of catheter-related infections 1, since P. 
mirabilis readily colonizes all available catheter types to 
form extensive biofilm communities 3. Expression of a po-
tent urease enzyme catalyzes the hydrolysis of urea in the 
urine, resulting in a rapid pH increase. The induced alka-
line environment initiates precipitation of polyvalent ions 
(including struvite (MgNH4PO4.6H2O) and carbonate-apa-
tite [Ca10(PO4CO3OH)6(OH)2]. Local supersaturation and 
subsequent accumulation of crystalline biofilms continues 
within the catheter until the flow of urine is obstructed, 
resulting in painful distention of the bladder, and serious 
symptomatic episodes such as acute pyelonephritis and 
septicemia 4. 
Since many long-term catheterized patients are in com-
munity care, bacteriological analysis of their urine is rarely 
performed 5. Consequently, colonization by P. mirabilis of-
ten remains undetected until the emergence of severe se-
quelae. Indeed, there is currently no reliable way of pre-
venting or accurately predicting when blockage may occur. 
Moreover, patients who commonly suffer from catheter 
blockage may have regular scheduled catheter changes in 
their care plan; however the irregularity of encrustation 
and blockage often results in needless or emergency 
changes, instigating patient trauma and avoidable 
healthcare costs 6. 
The concept of using urinary pH elevation to provide an 
‘early warning’ of catheter blockage has been explored pre-
viously via the covalent linkage of the pH indicator bromo-
thymol blue to cellulose acetate polymer. Despite success-
ful in vitro 7 and clinical assessments 8 of this system, this 
sensor was deemed unsuitable for commercial develop-
ment. Hence, the system was modified to improve com-
mercial viability via the manufacture of a silicone-based 
formulation with the incorporated indicator and hydro-
philic filler. The sensor was housed within a small polyvinyl 
chloride connecter, located in the junction between cathe-
ter and drainage bag, and proved promising both in vitro 
and in clinical studies. However, the ‘early warning’ of 
catheter blockage in human trials was >18 days, thus calling 
into question whether this system can be considered an in-
dicator of imminent catheter blockage.  
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Herein, we report the development of a simple ‘lozenge’ 
sensor placed directly into the drainage bag, to signal im-
pending catheter encrustation and blockage following in-
fection by P. mirabilis utilizing urinary pH as a proxy indi-
cator. The system is based on previously published tech-
nology 9, and comprises a cylindrical hydrogel reservoir 
(poly (vinyl-alcohol) (PVA)), containing the self-quench-
ing fluorescent dye 5(6)-carboxyfluorescein (CF). The hy-
drogel matrix is completely encapsulated and sealed by a 
pH-sensitive ‘trigger’ layer, composed of EUDRAGIT®S 100 
(poly(methyl methacrylate-co-methacrylic acid)). Eleva-
tion of urinary pH following P. mirabilis infection causes 
swelling of the EUDRAGIT®S 100 trigger layer, releasing the 
dye to result in a clear visual colour change within the cath-
eter drainage bag.  Unlike the previously reported technol-
ogy, the updated system avoids a potential adverse in vivo 
effects such as urethral inflammation 10, or promotion of 
microbial adhesion via deposition of a conditioning film on 
the luminal and external catheter surfaces 11. Furthermore, 
localized dye release within the drainage bag, without the 
spatial constraints of the catheter tip allows for a greater 
concentration of dye to be released within the visible por-
tion of the catheterized urinary tract, resulting in a clear 
visual colour change of residual urine to warn of impend-
ing blockage and allow sufficient time for clinical interven-
tion.  
METHODS:  
Analysis of 5(6)-Carboxyfluorescein Properties 
PH-Dependency  
The pH-dependent response of CF was assessed via pH 
adjustment of 0.5 mM CF solution (in HEPES buffer) 
within the range of pH 2-10 in 0.5 increments. A SPECTRO-
star Omega microplate reader (BMG Labtech, UK) was 
used to monitor fluorescence endpoints, using excitation 
and emission wavelengths of 485 ± 12 and 520 nm, respec-
tively. 
Concentration Quenching 
Dilutions from CF stock (50 mM) were undertaken to 
achieve a concentration range of 10 mM – 10 nM in HEPES 
buffer. Dilutions were adjusted to pH 6, 7 and 8 accord-
ingly via dropwise addition of NaOH/HCl (1M). Fluores-
cence endpoint measurements were read on a microplate 
reader.  
Preparation of EUDRAGIT®S 100 Solution  
An organic dip coating solution of EUDRAGIT®S 100 (av-
erage molecular weight of 150,000 g/mol) (Evonik indus-
tries, Germany) was prepared as previously reported 9 and 
stored at room temperature until required. 
Preparation of pH-Sensitive Lozenge Sensors 
To CF solution (50 mM, adjusted to pH 6) was added 
PVA (14,600-18,600 g/mol) (10% w/v) and heated to 97 °C 
with constant stirring to facilitate diffusion. The resultant 
hydrogel (1 ml) was cast into a 24-well microplate contain-
ing a 2 cm length of sterilized cotton thread, and stored at 
-20 °C overnight to promote cryogenic gelation. Sensors 
were thawed at room temperature (4 h) before dip coating 
with the EUDRAGIT®S 100 trigger layer via suspension from 
the thread. Sensors were manually dip-coated 50 times, 
with a 5 minute solvent evaporation period at room tem-
perature between each coating. Coated sensors were stored 
at 4 °C until required.  
Evaluation of Sensor Performance  
  In Vitro Bladder Models 
Bladder model setup and operation was followed as pre-
viously reported 9. Artificial urine was prepared according 
to 12 and supplied to the bladders via a peristaltic pump at 
a flow rate of 0.75 ml/min. Models simulating late-stage in-
fection were inoculated directly with clinical isolates of P. 
mirabilis B4 or E. coli NMS59 bacteria (108 colony forming 
units/ml (CFU/ml)). Two individual sensors were added 
aseptically to each drainage bag, and observed visual 
changes in urine colour were correlated with measured flu-
orescence response within the drainage bag. Fluorescence 
emission was quantified using a microplate reader as pre-
viously described. 
Bacterial Cultures 
Prototype sensors were evaluated for species selectivity 
using live cultures of P. mirabilis B4 and E. coli NSM59 clin-
ical isolates (~5 x106 CFU/ml). To artificial urine media (10 
ml) was added bacterial overnight culture (10 μl). Coated 
sensors were added to subcultures, and changes in pH, and 
fluorescence response as a function of dye release were 
measured via sequential sampling. 
Results and Discussion 
This study describes the initial proof-of-concept devel-
opment and in vitro evaluation of a novel medical device 
for the advance warning of urinary catheter blockage fol-
lowing infection by P. mirabilis. The dual-layered poly-
meric lozenge sensor is shown in Figure 1. 
The sensor provides an in situ fluorescent signal, visible 
to the naked eye, which detects expression of bacterial ure-
ase from P. mirabilis via the use of pH as a intermediary 
indicator. The outer ‘shell’ of the lozenge is formed of the 
pH-sensitive polymer  EUDRAGIT®S 100, containing a ratio 
of carboxyl: ester groups of 1:2 The pH gradient existing in 
the drainage bag as a result of the pathological conditions 
of P. mirabilis is sufficient to cause  a morphological change 
in the polymeric structure. Once the pH or the urine media 
is raised to pH 7, the carboxylic acid moieties become 
deprotonated, and the network begins to swell as a conse-
quence of repulsion. This allows penetration of the sur-
rounding liquid media, and thus the liberation of the en-
capsulated fluorescent dye. The resultant colour change 
within the drainage bag (pale yellow to fluorescent yel-
low/green) 13. 
Diagnosis of CAUTI remains a considerable challenge for 
clinical staff and point-of-care practitioners. Often, non-
evidence based approaches are still considered the most ef-
fective at predicting bacteriuria (such as discolored or mal-
odorous urine), with a dipstick of urine being commonly 
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used as a diagnostic tool. As such, catheter-associated 
asymptomatic bacteriuria (i.e. the presence of bacteria in 
the urine without clinical symptoms) is often being misdi-
agnosed as CAUTI and inappropriately treated with antibi-
otics 14. The introduction of simple, point-of-care diagnos-
tic devices such as the one described in this report may 
help to avoid the unnecessary prescription and overuse of 
antibiotics, thus encouraging a paradigm shift towards tar-
geted prescribing and antibiotic stewardship,  potentially 
aiding the preservation of the utility of antimicrobial 
agents 15.  
Analysis of 5(6)-Carboxyfluorescein 
The suitability of CF for the in situ sensing of CAUTI, and 
the mechanism by which the fluorescent signal propagates 
from the sensors within the drainage bag were important 
considerations when formulating the prototype sensors.  
Recent studies undertaken by Thet et al. 16 have investi-
gated the use of CF within a hydrogel wound dressing for 
the early detection of model pathogenic wound biofilms. 
Clear colourmetric detection in response to cytotoxins or 
other virulence factors was achieved, via the release on CF 
dye from a hydrogel matrix, demonstrating a change in mi-
crobiological state and allowing for rapid intervention. 
This work aims to improve the visual response gained in 
previous work by releasing CF into a large volume of liquid 
media, thereby enhancing the colourmetric signal ob-
served.  
Above the self-quenching concentration 17 during encap-
sulation within the hydrogel matrix, the dye is quenched 
owing to the formation of non-fluorescent dimers. Upon 
release of the dye into the urine diluent the concentration 
is sufficiently lowered such that the self-quenching is in-
hibited and the fluorescence activated (Figure 2A). Fur-
thermore, greater diluent pH has been shown to directly 
improve the observed fluorescence signal output (Figure 
2B). Since the pH of infected urine is highly alkaline (~pH 
8), this may further aid the visualization of the resultant 
urinary color change.   
In Vitro Evaluation of Prototype Sensors: Bacterial 
Cultures 
Urinary pH elevation following ex-
pression of urease by P. mirabilis 
Polymeric 
EUDRAGIT
®
S 100 
‘trigger’ layer 
PVA reservoir layer containing 5(6)-carboxyfluorescein 
Figure 1. A) Schematic representation and B) photographs of dual-layered polymeric lozenge sensor degradation and release 
of 5(6)-carboxyfluorescein. Generation of an in situ fluorescent signal provides ‘early warning’ of catheter blockage via de-
tection of alkaline urine as a result of P.mirabilis expression of bacterial urease.   
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Figure 2. Analysis of 5(6)-carboxyfluorescein properties. A) De-
pendence of fluorescence emission on CF concentration at pH 6, 
7 and 8, showing self-quenching at 10 mM. (Inset: visual represen-
tation of CF fluorescence at concentrations 50 nM -50 mM at pH 
8). B) Dependence of fluorescence emission on pH. (Inset: chem-
ical structure of CF). Data shown is the mean of triplicate repeats. 
Error bars represent standard error of the mean (SEM). 
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Initial assessment of lozenge sensors in artificial urine 
supernatants of P. mirabilis and the urease-negative uro-
pathogen E. coli confirmed dye release in response to ele-
vated urinary pH (Figure S1). Further analysis within live 
bacterial cultures exhibited selective release of CF in re-
sponse to the onset of infection by P. mirabilis (Figure 3). 
Evaluation of sensor performance over a 2 hour period, 
within which the urinary pH was raised (Figure 3A) from 
pH 6.1 (corresponding to an infection of 5.3 x106 CFU/ml) 
to 8.55 (corresponding to an infection of 2.3 x107 CFU/ml 
(Figure S2)) was found to correspond to a rapid and ob-
servable increase in fluorescence response as a function of 
CF release from the hydrogel matrix (Figure 3B). No signif-
icant fluorescence output was observed within the control 
culture of E. coli, owing to its inability to express urease, 
and hence, cause catheter blockage.  
Investigation into the kinetics of initial CF-release from 
lozenge sensors (Figure S3) revealed that the rate of release 
within the first 15 minutes of exposure to buffer at pH 7 was 
5.3 x10-8 at pH 7 (rising to 1.5 x10-7 mol dm-3 min-1 at pH 8) 
with a maximum CF release of approximately 3.5 mM after 
120 minutes. Hence, despite only approximately 14% of the 
encapsulated dye being released from the PVA reservoir, 
the resultant luminescence lies within the most fluorescent 
concentration region of the fluorescent chromophore (Fig-
ure 1A). In effect, the conservation of the majority of the 
dye within the hydrogel sensor may serve to retain signal 
strength over a longer period of time.  
In Vitro Evaluation of Prototype Sensors: Labora-
tory Model of Catheterized Bladder 
The performance of the dual-layered lozenge sensors to 
signal the onset of catheter blockage was tested using the 
in vitro bladder model system (originally described by 
Stickler et al., 1999), which replicates the full closed drain-
age system, and represents the in vivo catheterized urinary 
tract. Sensor ‘switch on’ was defined as the point at which 
a visual colour change was observed in residual urine 
within the drainage bag. Since the application of this tech-
nology requires the signal to be easily observable without 
the use of specialist equipment, the point of sensor switch 
on was subjectively judged by eye under ambient lighting. 
Observation of visual dye release prompted quantitative 
analysis of urinary fluorescence (Figure 4), such that the 
concentration of CF in the diluent could be estimated. The 
response of lozenge sensors to E. coli was also assessed to 
determine the selectivity of the sensors towards urease-
positive species. 
 Dye release and consequent visual urinary colour change 
within the drainage bags was observed after 3 hours (urine 
pH 7.2), corresponding to approximately 2 mM CF released 
(doubling by the point of blockage to ~4 mM) (Figure 4).  
Average blockage time of P. mirabilis infected models oc-
curred at 17.5 hours after the flow of urine to bladders was 
0 2 0 4 0 6 0 8 0 1 0 0 1 2 0
5
6
7
8
9
T im e  /m in u te s
p
H
P . m ira b ilis B 4
E . c o li N S M 59
0 2 0 4 0 6 0 8 0 1 0 0 1 2 0
0
1 0 0 0 0
2 0 0 0 0
3 0 0 0 0
T im e  /m in u te s
F
lu
o
re
s
c
e
n
c
e
 I
n
te
n
s
it
y
 /
R
F
U
P . m ira b ilis B 4
E . c o li N S M 59
B 
Figure 3. Analysis of sensor performance in 1:100 artificial 
urine subcultures, modelling the onset of catheter-associ-
ated urinary tract infection. A) pH elevation of artificial 
urine subcultures of P. mirabilis B4 and E. coli NSM59. B) 
Corresponding fluorescence emission of prototype sensors 
upon release of CF dye into artificial urine subcultures. 
Data shown is the mean of triplicate repeats. Error bars rep-
resent SEM.  
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Figure 4: Quantitative analysis of dye release into resid-
ual artificial urine of P. mirabilis-infected models at ex-
periment start (0 hours), point of visual colour change (3 
hours) and catheter blockage (17.5 hours). Data shown 
are the mean of triplicate repeats. Error bars represent 
standard error of the mean (SEM). 
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initiated (urine pH 8.6). Hence, the bag sensors achieved 
an average early warning of catheter blockage of 14.5 hours, 
with a range of 12.5-18 hours. The appearance and progres-
sion of a clear and unambiguous colour change (Figures 
5A-D) within the drainage bag was comparable with results 
seen previously 5,9, and was deemed sufficient to allow in-
tervention before the manifestation of serious clinical 
complications. Control bladders inoculated with E. coli ex-
hibited negligible fluorescence emission throughout the 
duration (23 hours) of the experiment (Figure 5D). 
The rapid catheter blockage (17.5 hours) achieved using 
the in vitro model of the catheterized bladder is achieved 
via inoculation with a large bacterial bioburden (108 
CFU/ml P. mirabilis B4) at the experimental start. This en-
deavours to replicate conditions within the catheterized 
urinary tract of  patients who frequently undergo recurrent 
catheter blockage , whereby the blocked catheter is re-
moved and quickly replaced directly into urine cultures of 
P. mirabilis at alkaline pH containing aggregates of micro-
crystalline material 18. 
The problem of blockage recurrence affects up to 50% of 
patients undergoing long-term indwelling catheterization 
19, and sufferers may experience occlusion as soon as 2 days 
post-catheter reinsertion 20. Since the sensors tested under 
these ‘worst case scenario’ conditions signalled catheter 
blockage sufficiently early (14.5 hours) to permit clinical in-
tervention, they provide a simple and convenient potential 
management system for recurring urinary catheter block-
age, a problem for which there is no current control 
method. 
The sensor design described in this work provides ad-
vantages over work described previously, owing to the spe-
cific dissolution pH threshold of the EUDRAGIT®S 100 trig-
ger layer.  Since the median healthy urinary pH is 6.2 21 with 
a mean range of 5.5-7.0, and the average voided urinary pH 
of patients with consistently blocking catheters is 7.85 22, 
the rapid and reproducible dissolution of EUDRAGIT®S 100 
above pH 7 23 allows for a less ambiguous result and poten-
tially fewer false positives when compared to the previ-
ously described bromothymol blue-based sensor 5, which 
responded to increasing urinary pH over a broad range (pH 
6-8). 
The design constraints of the current Foley catheter sys-
tem were also important considerations in the design of 
the sensor. Since the current catheter design has remained 
unchanged for decades 24, any technological advances in 
the control of CAUTI requiring the fabrication of addi-
tional components or redesign of the catheter/ closed 
drainage system may well be rejected by patients and car-
ers alike, owing to the introduction of additional cost or 
complexity. Indeed, some of these issues were highlighted 
in the pilot scale clinical trials of the bromothymol blue 
sensor 6, where the infection indicator was inserted as a 
connector in the junction between the catheter and drain-
age bag. Some participants reported leakage around the 
sensor, or expressed concern over the additional length 6. 
In contrast, the work described here fits well with existing 
manufacturing processes and all available drainage bag de-
signs, although the insertion of the sensor into the bag 
would need to occur at the point of manufacture, such that 
the sterility of the closed drainage system is not compro-
mised at the point-of-care. Perhaps the most important ad-
vantage of the bag-based system employed here is the po-
tential to incorporate antimicrobial coatings to the cathe-
ter tip, for example those containing bacteriophage 25 or 
metal oxide nanoparticles 26 to create a theranostic system 
whereby the onset of blockage is delayed by the therapeu-
tic coating (thus extending catheter lifetime), and the sub-
sequent elution/failure of the antimicrobial is signalled by 
the diagnostic sensor visible within the drainage bag. 
 
Figure 5. A) Appearance of drainage bag at experiment start (0 hours). B) Point of qualitative visual colour change (3 hours) 
in bladder model infected with 108 CFU/ml P.mirabilis B4. C) Colour change of artificial urine at point of catheter blockage 
(17.5 hours) in bladder model inoculated with P. mirabilis B4, and D) in bladder model inoculated with 108 CFU/ml E. coli 
NSM59. No visual colour change was observed for the urease-negative species. 
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Conclusion 
In summary, this work describes the development of a 
simple, drainage bag-based sensor for the early warning of 
catheter blockage following infection by P. mirabilis. Since 
many patients undergoing long-term indwelling catheteri-
zation are in community care, the collection and analysis 
of urine samples can be problematic. The system described 
here provides a convenient alternative, allowing the pa-
tient or carer to be informed of imminent blockage such 
that appropriate intervention may be facilitated. Evalua-
tion of coating performance in an in vitro bladder model 
showed that lozenge sensors permitted 14.5 hours warning 
of catheter blockage under conditions of established infec-
tion. However, it is worth noting that this system is not 
fully representative of the in vivo catheterized urinary tract. 
Further clinical studies are thus required to analyse the 
coating performance in light of the full complexity and var-
iation of the in vivo conditions. Overall, sensor perfor-
mance was comparable to other reported sensor systems, 
although the implementation of this approach provides 
significant advantages both in terms of response location 
and manufacturing considerations 
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